<!-- html table generated in R 3.5.3 by xtable 1.8-4 package -->
<!-- Tue Jun  4 15:21:30 2019 -->
<table border=1>
<tr> <th>  </th> <th> GOBPID </th> <th> Pvalue </th> <th> OddsRatio </th> <th> ExpCount </th> <th> Count </th> <th> Size </th> <th> Term </th> <th> Genes </th>  </tr>
  <tr> <td> 1 </td> <td align="center"> GO:0006069 </td> <td align="right"> 0.00 </td> <td align="right"> 14.61 </td> <td align="right"> 0.40 </td> <td align="right">   4 </td> <td align="right">  12 </td> <td> ethanol oxidation </td> <td> ADH1A, ADH1B, ADH1C, ALDH1B1 </td> </tr>
  <tr> <td> 2 </td> <td align="center"> GO:0097267 </td> <td align="right"> 0.00 </td> <td align="right"> 14.59 </td> <td align="right"> 0.30 </td> <td align="right">   3 </td> <td align="right">   9 </td> <td> omega-hydroxylase P450 pathway </td> <td> CYP1A2, CYP2C19, CYP2U1 </td> </tr>
  <tr> <td> 3 </td> <td align="center"> GO:0097154 </td> <td align="right"> 0.00 </td> <td align="right"> 13.01 </td> <td align="right"> 0.43 </td> <td align="right">   4 </td> <td align="right">  13 </td> <td> GABAergic neuron differentiation </td> <td> INHBA, RAC3, CNTN2, FEZF2 </td> </tr>
  <tr> <td> 4 </td> <td align="center"> GO:0033539 </td> <td align="right"> 0.00 </td> <td align="right"> 12.50 </td> <td align="right"> 0.33 </td> <td align="right">   3 </td> <td align="right">  10 </td> <td> fatty acid beta-oxidation using acyl-CoA dehydrogenase </td> <td> ETFB, ETFDH, GCDH </td> </tr>
  <tr> <td> 5 </td> <td align="center"> GO:0016338 </td> <td align="right"> 0.00 </td> <td align="right"> 8.13 </td> <td align="right"> 0.77 </td> <td align="right">   5 </td> <td align="right">  23 </td> <td> calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules </td> <td> CLDN11, CLDN10, CLDN15, CLDN22, CLDN19 </td> </tr>
  <tr> <td> 6 </td> <td align="center"> GO:0070593 </td> <td align="right"> 0.01 </td> <td align="right"> 6.73 </td> <td align="right"> 0.53 </td> <td align="right">   3 </td> <td align="right">  16 </td> <td> dendrite self-avoidance </td> <td> CNTN2, CNTN6, CNTN4 </td> </tr>
  <tr> <td> 7 </td> <td align="center"> GO:0042738 </td> <td align="right"> 0.01 </td> <td align="right"> 6.49 </td> <td align="right"> 0.73 </td> <td align="right">   4 </td> <td align="right">  22 </td> <td> exogenous drug catabolic process </td> <td> CYP1A2, CYP2A6, CYP2C19, CYP2U1 </td> </tr>
  <tr> <td> 8 </td> <td align="center"> GO:0045737 </td> <td align="right"> 0.02 </td> <td align="right"> 6.25 </td> <td align="right"> 0.57 </td> <td align="right">   3 </td> <td align="right">  17 </td> <td> positive regulation of cyclin-dependent protein serine/threonine kinase activity </td> <td> CKS1B, CKS2, PDGFB </td> </tr>
  <tr> <td> 9 </td> <td align="center"> GO:0140131 </td> <td align="right"> 0.02 </td> <td align="right"> 6.25 </td> <td align="right"> 0.57 </td> <td align="right">   3 </td> <td align="right">  17 </td> <td> positive regulation of lymphocyte chemotaxis </td> <td> PTK2B, CXCL14, CXCL13 </td> </tr>
  <tr> <td> 10 </td> <td align="center"> GO:0007413 </td> <td align="right"> 0.01 </td> <td align="right"> 6.15 </td> <td align="right"> 0.77 </td> <td align="right">   4 </td> <td align="right">  23 </td> <td> axonal fasciculation </td> <td> EPHA3, CNTN2, FEZF2, CNTN4 </td> </tr>
  <tr> <td> 11 </td> <td align="center"> GO:0021895 </td> <td align="right"> 0.01 </td> <td align="right"> 6.15 </td> <td align="right"> 0.77 </td> <td align="right">   4 </td> <td align="right">  23 </td> <td> cerebral cortex neuron differentiation </td> <td> PAFAH1B1, RAC3, CNTN2, FEZF2 </td> </tr>
  <tr> <td> 12 </td> <td align="center"> GO:0009200 </td> <td align="right"> 0.02 </td> <td align="right"> 5.83 </td> <td align="right"> 0.60 </td> <td align="right">   3 </td> <td align="right">  18 </td> <td> deoxyribonucleoside triphosphate metabolic process </td> <td> GUK1, TYMS, SAMHD1 </td> </tr>
  <tr> <td> 13 </td> <td align="center"> GO:0021697 </td> <td align="right"> 0.02 </td> <td align="right"> 5.47 </td> <td align="right"> 0.63 </td> <td align="right">   3 </td> <td align="right">  19 </td> <td> cerebellar cortex formation </td> <td> ATP7A, CBLN1, GRID2 </td> </tr>
  <tr> <td> 14 </td> <td align="center"> GO:0033630 </td> <td align="right"> 0.02 </td> <td align="right"> 5.47 </td> <td align="right"> 0.63 </td> <td align="right">   3 </td> <td align="right">  19 </td> <td> positive regulation of cell adhesion mediated by integrin </td> <td> RAC3, CXCL13, IFT74 </td> </tr>
  <tr> <td> 15 </td> <td align="center"> GO:0090662 </td> <td align="right"> 0.00 </td> <td align="right"> 5.22 </td> <td align="right"> 1.10 </td> <td align="right">   5 </td> <td align="right">  33 </td> <td> ATP hydrolysis coupled transmembrane transport </td> <td> FXYD2, ATP6V0C, ATP6V1C1, ATP6V1E1, ATP6V0E2 </td> </tr>
  <tr> <td> 16 </td> <td align="center"> GO:0010042 </td> <td align="right"> 0.03 </td> <td align="right"> 5.15 </td> <td align="right"> 0.67 </td> <td align="right">   3 </td> <td align="right">  20 </td> <td> response to manganese ion </td> <td> ATP7A, IREB2, ATP13A2 </td> </tr>
  <tr> <td> 17 </td> <td align="center"> GO:0019373 </td> <td align="right"> 0.03 </td> <td align="right"> 5.15 </td> <td align="right"> 0.67 </td> <td align="right">   3 </td> <td align="right">  20 </td> <td> epoxygenase P450 pathway </td> <td> CYP1A2, CYP2A6, CYP2C19 </td> </tr>
  <tr> <td> 18 </td> <td align="center"> GO:0032332 </td> <td align="right"> 0.03 </td> <td align="right"> 5.15 </td> <td align="right"> 0.67 </td> <td align="right">   3 </td> <td align="right">  20 </td> <td> positive regulation of chondrocyte differentiation </td> <td> GLI3, ZBTB16, GDF6 </td> </tr>
  <tr> <td> 19 </td> <td align="center"> GO:0046716 </td> <td align="right"> 0.03 </td> <td align="right"> 5.15 </td> <td align="right"> 0.67 </td> <td align="right">   3 </td> <td align="right">  20 </td> <td> muscle cell cellular homeostasis </td> <td> LAMP2, PFKM, LARGE2 </td> </tr>
  <tr> <td> 20 </td> <td align="center"> GO:0097150 </td> <td align="right"> 0.03 </td> <td align="right"> 5.15 </td> <td align="right"> 0.67 </td> <td align="right">   3 </td> <td align="right">  20 </td> <td> neuronal stem cell population maintenance </td> <td> SS18, SRRT, ASPM </td> </tr>
  <tr> <td> 21 </td> <td align="center"> GO:0098664 </td> <td align="right"> 0.01 </td> <td align="right"> 4.87 </td> <td align="right"> 0.93 </td> <td align="right">   4 </td> <td align="right">  28 </td> <td> G protein-coupled serotonin receptor signaling pathway </td> <td> CHRM1, HTR1E, HTR4, HTR5A </td> </tr>
  <tr> <td> 22 </td> <td align="center"> GO:0050951 </td> <td align="right"> 0.03 </td> <td align="right"> 4.86 </td> <td align="right"> 0.70 </td> <td align="right">   3 </td> <td align="right">  21 </td> <td> sensory perception of temperature stimulus </td> <td> CALCA, KCNK4, PRDM12 </td> </tr>
  <tr> <td> 23 </td> <td align="center"> GO:0051693 </td> <td align="right"> 0.01 </td> <td align="right"> 4.72 </td> <td align="right"> 1.20 </td> <td align="right">   5 </td> <td align="right">  36 </td> <td> actin filament capping </td> <td> EPS8, SPTAN1, SPTBN5, LMOD3, SCIN </td> </tr>
  <tr> <td> 24 </td> <td align="center"> GO:0055090 </td> <td align="right"> 0.01 </td> <td align="right"> 4.72 </td> <td align="right"> 1.20 </td> <td align="right">   5 </td> <td align="right">  36 </td> <td> acylglycerol homeostasis </td> <td> APOC2, XBP1, NR1H4, ANGPTL3, MIR33A </td> </tr>
  <tr> <td> 25 </td> <td align="center"> GO:0032786 </td> <td align="right"> 0.01 </td> <td align="right"> 4.67 </td> <td align="right"> 0.97 </td> <td align="right">   4 </td> <td align="right">  29 </td> <td> positive regulation of DNA-templated transcription, elongation </td> <td> ERCC6, SUPT5H, CCNK, BTBD18 </td> </tr>
  <tr> <td> 26 </td> <td align="center"> GO:0042451 </td> <td align="right"> 0.04 </td> <td align="right"> 4.60 </td> <td align="right"> 0.73 </td> <td align="right">   3 </td> <td align="right">  22 </td> <td> purine nucleoside biosynthetic process </td> <td> GUK1, NT5E, NME9 </td> </tr>
  <tr> <td> 27 </td> <td align="center"> GO:0015991 </td> <td align="right"> 0.02 </td> <td align="right"> 4.49 </td> <td align="right"> 1.00 </td> <td align="right">   4 </td> <td align="right">  30 </td> <td> ATP hydrolysis coupled proton transport </td> <td> ATP6V0C, ATP6V1C1, ATP6V1E1, ATP6V0E2 </td> </tr>
  <tr> <td> 28 </td> <td align="center"> GO:0007141 </td> <td align="right"> 0.04 </td> <td align="right"> 4.37 </td> <td align="right"> 0.77 </td> <td align="right">   3 </td> <td align="right">  23 </td> <td> male meiosis I </td> <td> DMC1, SYCP3, BTBD18 </td> </tr>
  <tr> <td> 29 </td> <td align="center"> GO:0034453 </td> <td align="right"> 0.04 </td> <td align="right"> 4.37 </td> <td align="right"> 0.77 </td> <td align="right">   3 </td> <td align="right">  23 </td> <td> microtubule anchoring </td> <td> DAG1, FGFR1OP, CLASP1 </td> </tr>
  <tr> <td> 30 </td> <td align="center"> GO:0035588 </td> <td align="right"> 0.04 </td> <td align="right"> 4.37 </td> <td align="right"> 0.77 </td> <td align="right">   3 </td> <td align="right">  23 </td> <td> G protein-coupled purinergic receptor signaling pathway </td> <td> ACPP, ADORA3, CNTN2 </td> </tr>
  <tr> <td> 31 </td> <td align="center"> GO:0042537 </td> <td align="right"> 0.04 </td> <td align="right"> 4.37 </td> <td align="right"> 0.77 </td> <td align="right">   3 </td> <td align="right">  23 </td> <td> benzene-containing compound metabolic process </td> <td> SRD5A2, UGT1A1, KYAT3 </td> </tr>
  <tr> <td> 32 </td> <td align="center"> GO:0060055 </td> <td align="right"> 0.04 </td> <td align="right"> 4.37 </td> <td align="right"> 0.77 </td> <td align="right">   3 </td> <td align="right">  23 </td> <td> angiogenesis involved in wound healing </td> <td> DAG1, B4GALT1, XBP1 </td> </tr>
  <tr> <td> 33 </td> <td align="center"> GO:0010259 </td> <td align="right"> 0.02 </td> <td align="right"> 4.32 </td> <td align="right"> 1.03 </td> <td align="right">   4 </td> <td align="right">  31 </td> <td> multicellular organism aging </td> <td> WRN, SERP1, HELT, RNF165 </td> </tr>
  <tr> <td> 34 </td> <td align="center"> GO:0031297 </td> <td align="right"> 0.02 </td> <td align="right"> 4.17 </td> <td align="right"> 1.07 </td> <td align="right">   4 </td> <td align="right">  32 </td> <td> replication fork processing </td> <td> WRN, SAMHD1, ETAA1, CENPX </td> </tr>
  <tr> <td> 35 </td> <td align="center"> GO:0006691 </td> <td align="right"> 0.04 </td> <td align="right"> 4.16 </td> <td align="right"> 0.80 </td> <td align="right">   3 </td> <td align="right">  24 </td> <td> leukotriene metabolic process </td> <td> CYP4F3, PTGR1, GGT6 </td> </tr>
  <tr> <td> 36 </td> <td align="center"> GO:0010669 </td> <td align="right"> 0.04 </td> <td align="right"> 4.16 </td> <td align="right"> 0.80 </td> <td align="right">   3 </td> <td align="right">  24 </td> <td> epithelial structure maintenance </td> <td> CXADR, SLC22A5, PBLD </td> </tr>
  <tr> <td> 37 </td> <td align="center"> GO:0006099 </td> <td align="right"> 0.02 </td> <td align="right"> 4.03 </td> <td align="right"> 1.10 </td> <td align="right">   4 </td> <td align="right">  33 </td> <td> tricarboxylic acid cycle </td> <td> IDH2, IDH3B, IREB2, PDHA2 </td> </tr>
  <tr> <td> 38 </td> <td align="center"> GO:0033572 </td> <td align="right"> 0.03 </td> <td align="right"> 3.89 </td> <td align="right"> 1.13 </td> <td align="right">   4 </td> <td align="right">  34 </td> <td> transferrin transport </td> <td> ATP6V0C, ATP6V1C1, ATP6V1E1, ATP6V0E2 </td> </tr>
  <tr> <td> 39 </td> <td align="center"> GO:0021587 </td> <td align="right"> 0.03 </td> <td align="right"> 3.77 </td> <td align="right"> 1.17 </td> <td align="right">   4 </td> <td align="right">  35 </td> <td> cerebellum morphogenesis </td> <td> ATP7A, CBLN1, GRID2, XRCC1 </td> </tr>
  <tr> <td> 40 </td> <td align="center"> GO:0051180 </td> <td align="right"> 0.03 </td> <td align="right"> 3.77 </td> <td align="right"> 1.17 </td> <td align="right">   4 </td> <td align="right">  35 </td> <td> vitamin transport </td> <td> AFM, GC, SLC19A2, CD320 </td> </tr>
  <tr> <td> 41 </td> <td align="center"> GO:1901880 </td> <td align="right"> 0.00 </td> <td align="right"> 3.73 </td> <td align="right"> 2.06 </td> <td align="right">   7 </td> <td align="right">  62 </td> <td> negative regulation of protein depolymerization </td> <td> EPS8, SPTAN1, CLASP1, SPTBN5, LMOD3, SCIN, TTBK2 </td> </tr>
  <tr> <td> 42 </td> <td align="center"> GO:0006826 </td> <td align="right"> 0.01 </td> <td align="right"> 3.66 </td> <td align="right"> 1.80 </td> <td align="right">   6 </td> <td align="right">  54 </td> <td> iron ion transport </td> <td> ATP6V0C, ATP6V1C1, ATP6V1E1, ATP7A, IREB2, ATP6V0E2 </td> </tr>
  <tr> <td> 43 </td> <td align="center"> GO:0010984 </td> <td align="right"> 0.03 </td> <td align="right"> 3.65 </td> <td align="right"> 1.20 </td> <td align="right">   4 </td> <td align="right">  36 </td> <td> regulation of lipoprotein particle clearance </td> <td> APOC2, NR1H4, MIR33A, MIR33B </td> </tr>
  <tr> <td> 44 </td> <td align="center"> GO:0072512 </td> <td align="right"> 0.03 </td> <td align="right"> 3.65 </td> <td align="right"> 1.20 </td> <td align="right">   4 </td> <td align="right">  36 </td> <td> trivalent inorganic cation transport </td> <td> ATP6V0C, ATP6V1C1, ATP6V1E1, ATP6V0E2 </td> </tr>
  <tr> <td> 45 </td> <td align="center"> GO:0021695 </td> <td align="right"> 0.02 </td> <td align="right"> 3.56 </td> <td align="right"> 1.53 </td> <td align="right">   5 </td> <td align="right">  46 </td> <td> cerebellar cortex development </td> <td> ATP7A, CBLN1, GRID2, CLP1, TTBK2 </td> </tr>
  <tr> <td> 46 </td> <td align="center"> GO:0009268 </td> <td align="right"> 0.04 </td> <td align="right"> 3.43 </td> <td align="right"> 1.27 </td> <td align="right">   4 </td> <td align="right">  38 </td> <td> response to pH </td> <td> ASIC2, SLC38A3, CHP1, KCNK4 </td> </tr>
  <tr> <td> 47 </td> <td align="center"> GO:0032732 </td> <td align="right"> 0.04 </td> <td align="right"> 3.43 </td> <td align="right"> 1.27 </td> <td align="right">   4 </td> <td align="right">  38 </td> <td> positive regulation of interleukin-1 production </td> <td> HK1, IFI16, SAA1, HMGB4 </td> </tr>
  <tr> <td> 48 </td> <td align="center"> GO:0034656 </td> <td align="right"> 0.02 </td> <td align="right"> 3.40 </td> <td align="right"> 1.60 </td> <td align="right">   5 </td> <td align="right">  48 </td> <td> nucleobase-containing small molecule catabolic process </td> <td> ENTPD3, GALT, NT5E, APOBEC2, ENTPD8 </td> </tr>
  <tr> <td> 49 </td> <td align="center"> GO:0030834 </td> <td align="right"> 0.02 </td> <td align="right"> 3.32 </td> <td align="right"> 1.63 </td> <td align="right">   5 </td> <td align="right">  49 </td> <td> regulation of actin filament depolymerization </td> <td> EPS8, SPTAN1, SPTBN5, LMOD3, SCIN </td> </tr>
  <tr> <td> 50 </td> <td align="center"> GO:0021879 </td> <td align="right"> 0.02 </td> <td align="right"> 3.25 </td> <td align="right"> 1.67 </td> <td align="right">   5 </td> <td align="right">  50 </td> <td> forebrain neuron differentiation </td> <td> ATP7A, INHBA, RAC3, CNTN2, FEZF2 </td> </tr>
  <tr> <td> 51 </td> <td align="center"> GO:0051653 </td> <td align="right"> 0.05 </td> <td align="right"> 3.15 </td> <td align="right"> 1.37 </td> <td align="right">   4 </td> <td align="right">  41 </td> <td> spindle localization </td> <td> PAFAH1B1, ESPL1, CLASP1, ASPM </td> </tr>
  <tr> <td> 52 </td> <td align="center"> GO:0032508 </td> <td align="right"> 0.02 </td> <td align="right"> 3.08 </td> <td align="right"> 2.10 </td> <td align="right">   6 </td> <td align="right">  63 </td> <td> DNA duplex unwinding </td> <td> ERCC6, XRCC6, RECQL, WRN, CHD8, HELB </td> </tr>
  <tr> <td> 53 </td> <td align="center"> GO:0051965 </td> <td align="right"> 0.02 </td> <td align="right"> 3.08 </td> <td align="right"> 2.10 </td> <td align="right">   6 </td> <td align="right">  63 </td> <td> positive regulation of synapse assembly </td> <td> ASIC2, CBLN1, EFNA5, GRID2, LRTM1, CLSTN2 </td> </tr>
  <tr> <td> 54 </td> <td align="center"> GO:0070098 </td> <td align="right"> 0.01 </td> <td align="right"> 3.01 </td> <td align="right"> 2.50 </td> <td align="right">   7 </td> <td align="right">  75 </td> <td> chemokine-mediated signaling pathway </td> <td> CCR8, PTK2B, CCL20, CCL24, CXCL13, CXCR6, ACKR3 </td> </tr>
  <tr> <td> 55 </td> <td align="center"> GO:0032781 </td> <td align="right"> 0.03 </td> <td align="right"> 2.98 </td> <td align="right"> 1.80 </td> <td align="right">   5 </td> <td align="right">  54 </td> <td> positive regulation of ATPase activity </td> <td> ATP4B, DNAJB6, GABARAPL2, TOR1AIP1, HSCB </td> </tr>
  <tr> <td> 56 </td> <td align="center"> GO:0033013 </td> <td align="right"> 0.04 </td> <td align="right"> 2.86 </td> <td align="right"> 1.86 </td> <td align="right">   5 </td> <td align="right">  56 </td> <td> tetrapyrrole metabolic process </td> <td> CYP1A2, IREB2, CD320, UGT1A1, CLYBL </td> </tr>
  <tr> <td> 57 </td> <td align="center"> GO:0060395 </td> <td align="right"> 0.03 </td> <td align="right"> 2.78 </td> <td align="right"> 2.30 </td> <td align="right">   6 </td> <td align="right">  69 </td> <td> SMAD protein signal transduction </td> <td> BMP8B, INHBA, GDF3, SUB1, PBLD, GDF6 </td> </tr>
  <tr> <td> 58 </td> <td align="center"> GO:0051893 </td> <td align="right"> 0.04 </td> <td align="right"> 2.75 </td> <td align="right"> 1.93 </td> <td align="right">   5 </td> <td align="right">  58 </td> <td> regulation of focal adhesion assembly </td> <td> EFNA5, EPHA3, CLASP1, BCAS3, DUSP22 </td> </tr>
  <tr> <td> 59 </td> <td align="center"> GO:0005977 </td> <td align="right"> 0.03 </td> <td align="right"> 2.74 </td> <td align="right"> 2.33 </td> <td align="right">   6 </td> <td align="right">  70 </td> <td> glycogen metabolic process </td> <td> GBE1, PFKM, RB1CC1, STK40, PPP1R3E, PPP1R3G </td> </tr>
  <tr> <td> 60 </td> <td align="center"> GO:0044042 </td> <td align="right"> 0.03 </td> <td align="right"> 2.70 </td> <td align="right"> 2.36 </td> <td align="right">   6 </td> <td align="right">  71 </td> <td> glucan metabolic process </td> <td> GBE1, PFKM, RB1CC1, STK40, PPP1R3E, PPP1R3G </td> </tr>
  <tr> <td> 61 </td> <td align="center"> GO:1990868 </td> <td align="right"> 0.02 </td> <td align="right"> 2.70 </td> <td align="right"> 2.76 </td> <td align="right">   7 </td> <td align="right">  83 </td> <td> response to chemokine </td> <td> CCR8, PTK2B, CCL20, CCL24, CXCL13, CXCR6, ACKR3 </td> </tr>
  <tr> <td> 62 </td> <td align="center"> GO:0060393 </td> <td align="right"> 0.05 </td> <td align="right"> 2.65 </td> <td align="right"> 2.00 </td> <td align="right">   5 </td> <td align="right">  60 </td> <td> regulation of pathway-restricted SMAD protein phosphorylation </td> <td> BMP8B, INHBA, GDF3, PBLD, GDF6 </td> </tr>
  <tr> <td> 63 </td> <td align="center"> GO:0051289 </td> <td align="right"> 0.04 </td> <td align="right"> 2.58 </td> <td align="right"> 2.46 </td> <td align="right">   6 </td> <td align="right">  74 </td> <td> protein homotetramerization </td> <td> ACPP, CD79A, SAMHD1, SRR, GBP5, CRTC2 </td> </tr>
  <tr> <td> 64 </td> <td align="center"> GO:0034308 </td> <td align="right"> 0.04 </td> <td align="right"> 2.54 </td> <td align="right"> 2.50 </td> <td align="right">   6 </td> <td align="right">  75 </td> <td> primary alcohol metabolic process </td> <td> ADH1A, ADH1B, ADH1C, ALDH1B1, RPE65, AWAT2 </td> </tr>
  <tr> <td> 65 </td> <td align="center"> GO:0007045 </td> <td align="right"> 0.04 </td> <td align="right"> 2.50 </td> <td align="right"> 2.53 </td> <td align="right">   6 </td> <td align="right">  76 </td> <td> cell-substrate adherens junction assembly </td> <td> EFNA5, EPHA3, PTK2B, CLASP1, BCAS3, DUSP22 </td> </tr>
  <tr> <td> 66 </td> <td align="center"> GO:0016241 </td> <td align="right"> 0.01 </td> <td align="right"> 2.50 </td> <td align="right"> 5.10 </td> <td align="right">  12 </td> <td align="right"> 153 </td> <td> regulation of macroautophagy </td> <td> ATP6V0C, ATP6V1C1, ATP6V1E1, MAPK8, SUPT5H, LAMTOR3, RB1CC1, TRIM13, ATP13A2, KIAA1324, SMCR8, ATP6V0E2 </td> </tr>
  <tr> <td> 67 </td> <td align="center"> GO:0001676 </td> <td align="right"> 0.02 </td> <td align="right"> 2.49 </td> <td align="right"> 3.40 </td> <td align="right">   8 </td> <td align="right"> 102 </td> <td> long-chain fatty acid metabolic process </td> <td> CYP1A2, CYP2A6, CYP2C19, HSD17B4, CYP4F3, SLC27A2, CYP2U1, ACOT12 </td> </tr>
  <tr> <td> 68 </td> <td align="center"> GO:0009062 </td> <td align="right"> 0.02 </td> <td align="right"> 2.49 </td> <td align="right"> 3.40 </td> <td align="right">   8 </td> <td align="right"> 102 </td> <td> fatty acid catabolic process </td> <td> CRAT, ETFB, ETFDH, GCDH, HSD17B4, CYP4F3, LPIN2, SLC27A2 </td> </tr>
  <tr> <td> 69 </td> <td align="center"> GO:0043244 </td> <td align="right"> 0.02 </td> <td align="right"> 2.49 </td> <td align="right"> 3.40 </td> <td align="right">   8 </td> <td align="right"> 102 </td> <td> regulation of protein complex disassembly </td> <td> EPS8, SPTAN1, CLASP1, SPTBN5, LMOD3, SCIN, SMCR8, TTBK2 </td> </tr>
  <tr> <td> 70 </td> <td align="center"> GO:0021766 </td> <td align="right"> 0.04 </td> <td align="right"> 2.47 </td> <td align="right"> 2.56 </td> <td align="right">   6 </td> <td align="right">  77 </td> <td> hippocampus development </td> <td> GLI3, HTR5A, PAFAH1B1, SRD5A2, XRCC1, FEZF2 </td> </tr>
  <tr> <td> 71 </td> <td align="center"> GO:0006720 </td> <td align="right"> 0.02 </td> <td align="right"> 2.38 </td> <td align="right"> 4.00 </td> <td align="right">   9 </td> <td align="right"> 120 </td> <td> isoprenoid metabolic process </td> <td> ABCA4, APOC2, CYP1A2, CYP2C19, RPE65, UGT1A1, NUS1, AWAT2, CYP26C1 </td> </tr>
  <tr> <td> 72 </td> <td align="center"> GO:0016999 </td> <td align="right"> 0.01 </td> <td align="right"> 2.38 </td> <td align="right"> 4.90 </td> <td align="right">  11 </td> <td align="right"> 147 </td> <td> antibiotic metabolic process </td> <td> ADH1A, ADH1B, ADH1C, ALDH1B1, CYP1A2, IDH2, IDH3B, IREB2, PDHA2, SRD5A2, UGT1A1 </td> </tr>
  <tr> <td> 73 </td> <td align="center"> GO:0033559 </td> <td align="right"> 0.04 </td> <td align="right"> 2.35 </td> <td align="right"> 3.13 </td> <td align="right">   7 </td> <td align="right">  94 </td> <td> unsaturated fatty acid metabolic process </td> <td> CYP1A2, CYP2A6, CYP2C19, HSD17B4, CYP4F3, PTGR1, CYP2U1 </td> </tr>
  <tr> <td> 74 </td> <td align="center"> GO:0061982 </td> <td align="right"> 0.03 </td> <td align="right"> 2.32 </td> <td align="right"> 3.63 </td> <td align="right">   8 </td> <td align="right"> 109 </td> <td> meiosis I cell cycle process </td> <td> CKS2, ESPL1, DMC1, SYCP3, CENPX, SYCE2, C14orf39, BTBD18 </td> </tr>
  <tr> <td> 75 </td> <td align="center"> GO:0019233 </td> <td align="right"> 0.04 </td> <td align="right"> 2.27 </td> <td align="right"> 3.23 </td> <td align="right">   7 </td> <td align="right">  97 </td> <td> sensory perception of pain </td> <td> ACPP, BDKRB1, CALCA, IAPP, KCNK4, PRDM12, FAM173B </td> </tr>
  <tr> <td> 76 </td> <td align="center"> GO:0022037 </td> <td align="right"> 0.05 </td> <td align="right"> 2.25 </td> <td align="right"> 3.26 </td> <td align="right">   7 </td> <td align="right">  98 </td> <td> metencephalon development </td> <td> ATP7A, CBLN1, GRID2, KCNC1, XRCC1, CLP1, TTBK2 </td> </tr>
  <tr> <td> 77 </td> <td align="center"> GO:1901568 </td> <td align="right"> 0.02 </td> <td align="right"> 2.24 </td> <td align="right"> 4.70 </td> <td align="right">  10 </td> <td align="right"> 141 </td> <td> fatty acid derivative metabolic process </td> <td> CYP1A2, CYP2A6, CYP2C19, GCDH, HSD17B4, CYP4F3, PTGR1, CYP2U1, GGT6, AWAT2 </td> </tr>
  <tr> <td> 78 </td> <td align="center"> GO:0090100 </td> <td align="right"> 0.05 </td> <td align="right"> 2.20 </td> <td align="right"> 3.33 </td> <td align="right">   7 </td> <td align="right"> 100 </td> <td> positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway </td> <td> BMP8B, CDKN2B, CREBBP, INHBA, GDF3, GDF6, RNF165 </td> </tr>
  <tr> <td> 79 </td> <td align="center"> GO:0009267 </td> <td align="right"> 0.04 </td> <td align="right"> 2.11 </td> <td align="right"> 4.46 </td> <td align="right">   9 </td> <td align="right"> 134 </td> <td> cellular response to starvation </td> <td> IFI16, LAMP2, MAPK8, WRN, XBP1, STK24, SLC38A3, GABARAPL2, KIAA1324 </td> </tr>
  <tr> <td> 80 </td> <td align="center"> GO:0050777 </td> <td align="right"> 0.05 </td> <td align="right"> 2.09 </td> <td align="right"> 4.00 </td> <td align="right">   8 </td> <td align="right"> 120 </td> <td> negative regulation of immune response </td> <td> BST2, IFI16, PSMB4, SAMHD1, PARP14, DUSP22, SAMSN1, CUEDC2 </td> </tr>
  <tr> <td> 81 </td> <td align="center"> GO:0140013 </td> <td align="right"> 0.04 </td> <td align="right"> 1.95 </td> <td align="right"> 5.33 </td> <td align="right">  10 </td> <td align="right"> 160 </td> <td> meiotic nuclear division </td> <td> CKS2, FANCA, ESPL1, DMC1, SYCP3, CENPX, SYCE2, ASPM, C14orf39, BTBD18 </td> </tr>
  <tr> <td> 82 </td> <td align="center"> GO:0031668 </td> <td align="right"> 0.02 </td> <td align="right"> 1.94 </td> <td align="right"> 8.09 </td> <td align="right">  15 </td> <td align="right"> 243 </td> <td> cellular response to extracellular stimulus </td> <td> CDKN2B, IFI16, IREB2, LAMP2, MAPK8, WRN, XBP1, STK24, AIFM1, NR1H4, SLC38A3, GABARAPL2, TXN2, KIF26A, KIAA1324 </td> </tr>
  <tr> <td> 83 </td> <td align="center"> GO:0006813 </td> <td align="right"> 0.02 </td> <td align="right"> 1.92 </td> <td align="right"> 7.59 </td> <td align="right">  14 </td> <td align="right"> 228 </td> <td> potassium ion transport </td> <td> FXYD2, ATP4B, PTK2B, KCNC1, KCNH1, KCNK1, KCNN2, KCNB2, CHP1, SLC24A2, TRPM5, KCNK4, CAB39, LRRC55 </td> </tr>
  <tr> <td> 84 </td> <td align="center"> GO:0071229 </td> <td align="right"> 0.03 </td> <td align="right"> 1.90 </td> <td align="right"> 6.56 </td> <td align="right">  12 </td> <td align="right"> 197 </td> <td> cellular response to acid chemical </td> <td> ATP7A, COL1A2, EPHA3, PTK2B, FFAR2, IREB2, PDGFB, XBP1, YES1, LAMTOR3, NR1H4, KCNK4 </td> </tr>
  <tr> <td> 85 </td> <td align="center"> GO:0051260 </td> <td align="right"> 0.03 </td> <td align="right"> 1.87 </td> <td align="right"> 7.81 </td> <td align="right">  14 </td> <td align="right"> 236 </td> <td> protein homooligomerization </td> <td> ANXA5, CD3G, B4GALT1, IAPP, KCNC1, MGST1, RS1, SLC1A1, DGKD, KCNB2, SPTBN5, KCTD12, RASEF, CLYBL </td> </tr>
  <tr> <td> 86 </td> <td align="center"> GO:0010951 </td> <td align="right"> 0.04 </td> <td align="right"> 1.77 </td> <td align="right"> 7.63 </td> <td align="right">  13 </td> <td align="right"> 229 </td> <td> negative regulation of endopeptidase activity </td> <td> BST2, CAST, COL6A3, IFI16, SERPINB2, SERPINA7, USP14, DNAJB6, WFDC2, TNFAIP8, CRIM1, BCL2L12, CST9L </td> </tr>
  <tr> <td> 87 </td> <td align="center"> GO:0060326 </td> <td align="right"> 0.03 </td> <td align="right"> 1.76 </td> <td align="right"> 8.86 </td> <td align="right">  15 </td> <td align="right"> 266 </td> <td> cell chemotaxis </td> <td> CALCA, CCR8, CXADR, PTK2B, FFAR2, PDGFB, SAA1, CCL20, CCL24, VAV1, CXCL14, CXCL13, CXCR6, ACKR3, HMGB4 </td> </tr>
  <tr> <td> 88 </td> <td align="center"> GO:0098742 </td> <td align="right"> 0.05 </td> <td align="right"> 1.74 </td> <td align="right"> 7.73 </td> <td align="right">  13 </td> <td align="right"> 234 </td> <td> cell-cell adhesion via plasma-membrane adhesion molecules </td> <td> CBLN1, CDH6, CXADR, EFNA5, GRID2, CNTN2, CNTN6, PCDHGC4, PCDHGA4, CLSTN2, CNTN4, CDHR3, CDHR4 </td> </tr>
  <tr> <td> 89 </td> <td align="center"> GO:0034976 </td> <td align="right"> 0.04 </td> <td align="right"> 1.73 </td> <td align="right"> 8.36 </td> <td align="right">  14 </td> <td align="right"> 251 </td> <td> response to endoplasmic reticulum stress </td> <td> RASGRF2, XBP1, USP14, AIFM1, PDIA4, TRIM13, AGR2, MAN1B1, UBXN4, SERP1, UFM1, YOD1, CHAC1, UBA5 </td> </tr>
   </table>
